Osteonecrosis of the jaw associated with pamidronate disodium

Lu Min,Wang Wei,Zhou Ying,Liang Yan,Cui Yimin,Guo Xiaohui

DOI: https://doi.org/10.3969/j.issn.1008-5734.2011.03.013

2011-01-01

Abstract:A 60-year-old man with type 2 diabetes mellitus received anⅣinfusion of pamidronate disodium 60 mg dissolved in 0.9%sodium chloride 500 ml,which was given within 4-5 hours via an infusion pump,for bone metastasis of small cell lung cancer. The dosing interval was once every 1-3 months.He received pamidronate 10 times within 17 months.Subsequently,the patient received head radiotherapy for brain metastasis.Two days before radiotherapy,he was given prednisone 10 mg thrice daily for 37 days. After radiotherapy completion,the patient was retreated with pamidronate disodium therapy,and the dosage and administration were the same as the previous regimen.He received pamidronate 5 times within one year.During this year,the patient experienced recurrent gingival swelling,pains and pyorrhea.Osteonecrosis of the jaw(ONJ) was diagnosed by dentists.ONJ was considered to be associated with pamidronate disodium,or both bisphosphonates and radiotherapy.